Month: August 2025

ROCKVILLE, Md., Aug. 01, 2025 (GLOBE NEWSWIRE) — I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced the pricing of an underwritten offering in the United States of 33,333,334 American Depositary Shares (ADSs) representing 76,666,668 ordinary shares at an offering price of $1.95 per ADS, for total gross proceeds of approximately $65 million. All of the ADSs to be sold in the offering will be offered by I-Mab. The offering is expected to close on August 5, 2025, subject to customary closing conditions. The offering included participation from new and existing investors including Everest Medicines, Janus Henderson Investors, Adage Capital Partners LP and Exome Asset Management. Leerink Partners is acting...

NEW ALBANY, Ohio, Aug. 01, 2025 (GLOBE NEWSWIRE) — Abercrombie & Fitch Co. (NYSE: ANF) will host its quarterly earnings conference call for all interested parties on Wednesday, August 27, 2025, at 8:30 a.m. ET. A press release detailing the company’s second quarter results is expected to be issued shortly after 7:30 a.m. ET.   In addition, a presentation of the second quarter results will be available on the company’s website at approximately 7:30 a.m. ET.Conference Call: To access the conference call by phone, participants will need to register to obtain a dial-in phone number and an access code. Register for the call using this link.   Webcast: To listen to a live webcast of the call, please visit corporate.abercrombie.com/investors/news-and-events/events/ and click the link to the webcast.   Replay: A replay...

CUPERTINO, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) — Aemetis, Inc. (NASDAQ: AMTX) announced that the company will host a conference call to review the release of its second quarter 2025 earnings report: Date: Thursday, August 7, 2025 Time: 11 am Pacific Time (PT) Live Participant Dial In (Toll Free): +1-888-506-0062 entry code 655740  Live Participant Dial In (International): +1-973-528-0011 entry code 655740 Webcast URL: https://www.webcaster4.com/Webcast/Page/2211/52764 Attendees may submit questions during the Q&A (Questions & Answers) portion of the conference call. The webcast will be available on the Company’s website (www.aemetis.com) under Investors/Conference Calls, along with the company presentation, recent announcements, and video recordings. The voice recording will be available through August 14, 2025, by...

CHARLESTOWN, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 55,450 restricted stock units (“RSUs”) to four newly hired employees. The RSUs vest in four equal installments on each one-year anniversary of the grant date until the fourth anniversary of the grant date. Vesting of the equity awards is subject to the applicable employee’s continued service with the Company through each applicable vesting date. This grant was made pursuant to the Company’s 2024 Inducement Stock Incentive Plan and was made as an inducement material to the employee’s acceptance of employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). About Solid BiosciencesSolid...

ROCKVILLE, Md. and SUZHOU, China, Aug. 01, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced today that the Company’s management will participate in the Evercore China Biotech Summit being held on August 19 – 21, 2025 in Shanghai, China. Management will be participating in a fireside chat moderated by the Evercore ISI Research team and one-on-one investor meetings at the conference. Investors interested in scheduling a meeting with the Ascentage Pharma management team should contact their Evercore representative. About Ascentage Pharma Group International Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or...

Hauppauge, NY, Aug. 01, 2025 (GLOBE NEWSWIRE) — – Cemtrex Inc. (Nasdaq: CETX), a technology company focused on intelligent security and industrial services, today issued a shareholder update from Chairman and CEO Saagar Govil outlining the Company’s progress across its core divisions and strategic roadmap for long-term growth: To our shareholders, Cemtrex today is stronger, sharper, and more focused than at any point in the last several years. We’ve been building deliberately investing in the right products, winning critical contracts, and executing a strategy that positions us to lead where the world is heading. Vicon: Momentum, Execution, and the Launch of NEXT Vicon, our intelligent security division, is performing. Since 2021, we’ve grown revenue from $21 million to a projected $36 million-plus for fiscal year 2025. Gross...

CARLSBAD, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) — Viasat, Inc. (NASDAQ:VSAT) (“Viasat” or “the Company”), a global leader in satellite communications, today issued the following statement in response to a letter from Carronade Capital Management. “Viasat consistently engages in dialogue with its shareholders and welcomes constructive input focused on maximizing shareholder value. As a leader in satellite infrastructure and connectivity, in-flight connectivity and critical military and government communication, Viasat is well-positioned to compete globally.  The Company’s Board of Directors and management team are committed to acting in the best interests of all shareholders. We are focused on executing Viasat’s strategy to strengthen our franchises’ earnings power, deliver sustainable, compelling operating and free cash...

DELAWARE, Ohio, Aug. 01, 2025 (GLOBE NEWSWIRE) — Greif (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, announced today it will permanently close the steel and polymer drum facility in Merced, California as part of its previously announced optimization efforts. The facility is expected to cease operation in September 2025. “Making the decision to close a facility is always difficult” said Greif President and CEO Ole Rosgaard. “I want to express my deep gratitude to our colleagues in Merced for their hard work over the years and the positive impact they’ve had on the company and surrounding community. We are committed to doing everything we can to make this transition as easy as possible, including providing severance packages and career placement services.” The decision to close the facility, which...

LANGHORNE, Pa., Aug. 01, 2025 (GLOBE NEWSWIRE) — NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced it has entered into definitive agreements for the issuance and sale of an aggregate of 413,044 shares of its common stock (the “Shares”) at $2.30 a share. In a concurrent private placement, NEXGEL also agreed to issue to the investors in the registered direct offering unregistered warrants to purchase up to an aggregate of 206,522 shares of common stock (the “Unregistered Warrants”). The Unregistered Warrants will have an exercise price of $4.25 per share and are exercisable immediately upon issuance with a term of five years from the date of issuance. Adam...

GREENWICH, Conn., Aug. 01, 2025 (GLOBE NEWSWIRE) — Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQG) (NasdaqGS: OXSQZ) (the “Company”) today announced that it has priced an underwritten public offering of $65 million in aggregate principal amount of 7.75% unsecured notes due 2030. The notes will mature on July 31, 2030, and may be redeemed in whole or in part at any time or from time to time at the Company’s option on or after July 31, 2027. The notes will bear interest at a rate of 7.75% per year payable quarterly on January 31, April 30, July 31, and October 31 of each year, commencing October 31, 2025. The offering is expected to close on August 7, 2025, subject to customary closing conditions. The Company has granted the underwriters an option to purchase up to an additional $9.75 million in aggregate principal...